Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
about
Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes.Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter StuPrevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update.Use of prolonged bivalirudin infusions following percutaneous coronary intervention.Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice.Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus.
P2860
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Comparison of prasugrel and cl ...... taneous coronary intervention.
@en
Comparison of prasugrel and cl ...... taneous coronary intervention.
@nl
type
label
Comparison of prasugrel and cl ...... taneous coronary intervention.
@en
Comparison of prasugrel and cl ...... taneous coronary intervention.
@nl
prefLabel
Comparison of prasugrel and cl ...... taneous coronary intervention.
@en
Comparison of prasugrel and cl ...... taneous coronary intervention.
@nl
P2860
P921
P356
P1476
Comparison of prasugrel and cl ...... utaneous coronary intervention
@en
P2093
Mazen Abu-Fadel
P2860
P304
P356
10.2147/VHRM.S5699
P407
P577
2009-11-02T00:00:00Z